Strumpell-Lorrain syndrome, or hereditary spastic paraplegia is a genetic disease of the central nervous system affecting the spinal cord and cerebellum. It represents a clinically heterogenous group of neurodegenerative disorders characterized by progressive spasticity and hyperreflexia of the lower limbs. Ocular abnormalities include keratitis, macular pigmentary abnormalities, juxtafoveolar retinal telangiectasis and choroidal neovascularization. We report the first case of choroidal neovascularization associated with Strupell-Lorrain syndrome treated successfully with intravitreal ranibizumab injection. (C) 2012 Elsevier Masson SAS. All rights reserved.
Intravitreal ranibizumab injection for choroidal neovascularization in Strumpell-Lorrain Syndrome / Tran, Thc; Baglin, G; Querques, Giuseppe. - In: JOURNAL FRANCAIS D'OPHTALMOLOGIE. - ISSN 0181-5512. - 35:5(2012), pp. 353-355. [10.1016/j.jfo.2011.12.004]
Intravitreal ranibizumab injection for choroidal neovascularization in Strumpell-Lorrain Syndrome
QUERQUES , GIUSEPPE
2012
Abstract
Strumpell-Lorrain syndrome, or hereditary spastic paraplegia is a genetic disease of the central nervous system affecting the spinal cord and cerebellum. It represents a clinically heterogenous group of neurodegenerative disorders characterized by progressive spasticity and hyperreflexia of the lower limbs. Ocular abnormalities include keratitis, macular pigmentary abnormalities, juxtafoveolar retinal telangiectasis and choroidal neovascularization. We report the first case of choroidal neovascularization associated with Strupell-Lorrain syndrome treated successfully with intravitreal ranibizumab injection. (C) 2012 Elsevier Masson SAS. All rights reserved.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
